Unlock instant, AI-driven research and patent intelligence for your innovation.

Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease

An oligonucleotide and TGF-technology, applied in the field of new drugs to prevent fibrosis and treat fibrosis-related diseases, can solve the problems of poorly understood and difficult effects of cellular factors

Inactive Publication Date: 2006-01-11
INST OF FIELD OPERATION SURGERY NO 3 MILITARY MEDICL UNIV PLA
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Predicting these structures of RNA in detail remains difficult, and the influence of cellular factors on them is poorly understood

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease
  • Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease
  • Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] 1. TGF-β 1 Preparation of mRNA: RT-PCR amplification containing mature TGF-β 1 The cDNA fragment of the protein and signal peptide, the length of the cDNA is 1.3kb, its 5' end contains a Hind III restriction site, and its 3' end contains an XbaI restriction site. The correct sequence was verified by cloning into the A / T vector and sequencing. Carry out Hind III-Xba I double enzyme digestion to the vector containing the target fragment respectively, and recover the gene fragment; pSP64(polyA) vector (Promega) is subjected to Hind III-Xba I double enzyme digestion, and after recovery, it is ligated with the above gene fragment overnight to obtain TGF-β with SP6 promoter 1 cDNA(811-2170) in vitro expression plasmid pSP64-TGF-β 1 (see picture 1). The expression plasmid was constructed as figure 2 shown. Linearized pSP64-TGF-β digested with EcoR I 1 In vitro transcription was performed as a template, and the mRNA was recovered and stored at -70°C for later use.

[0...

Embodiment 2

[0038] 1. TGF-β 1 Preparation of mRNA: same as Example 1.

[0039] 2. Design and synthesis of ssDNA random library: 2 ssDNA random libraries were designed and synthesized, with random sequences of 17 and 26 bases in length and wing lengths of 20 and 32 bases; synthesized by Espec Oligo Service Corp. in Japan, and the synthesis scale More than 6nmol, more than 98% of the full-length sequence.

[0040] Its specific composition is: 5'-accagcggactcgtgc-N 26 -cagacgactcgcccga-3'

[0041] 5'-accagcggac-N 17 -actcgcccga-3'

[0042] 3. Target TGF-β 1 Oligonucleotide screening of mRNA: same as Example 1.

[0043] 4. Cluster analysis of antisense oligonucleotide sequences: same as in Example 1.

[0044] 5. Optimization of antisense oligonucleotides: Through the screening of 3 random oligonucleotide libraries, it was found that the ssDNA library with a random sequence length of 20 bases and a wing length of 32 bases had the highest binding efficiency, and had the hig...

Embodiment 3

[0046] 1. Synthesis of thio-modified antisense oligonucleotide sequences: synthesized by an automatic DNA synthesizer and thio-modified during the synthesis process, the synthesis scale is 15OD, and purified by gel cutting after PAGE denaturing gel electrophoresis.

[0047] 2. Activity evaluation of antisense oligonucleotides: human oral epidermal carcinoma cells (KB) were seeded in 96-well plates, 4×10 3 Cells / well, 37°C, 5% CO 2 Incubate for 18-20h. After 60-80% cell confluence, use Opti-MEMI Reduced Serum Medium (Gibco) in serum-free state, liposome Oligofectamin (Invitrogen) for cell transfection, the total volume is 100μl, and the final concentration of antisense oligonucleotide is 200nmol / L. The above 18 sequences were transfected into KB cells respectively, and after 5 hours of action, 50 μl of Opti-MEM I Reduced Serum Medium containing 6% fetal bovine serum was added and cultured for 24 hours. The cells added with culture medium alone were used as blank control, th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

18 antisense oligonucleotides used to suppress the gene expression of transforming growth factor is synthesized by SELEX process for preventing and treating the diseases associated with fibrosis. The cells of human oral epidermal cancer with high expression to transforming growth factor and cultured externally are used to screen and evaluating said 18 antisense oligonuleotides. It is found out that the oligonucleotides TGF252, TGF348, TGF471, TGF554, TGF982, TGF1000, TGF1210, TGF1312 and their chemically modified substances can effectively suppress the expression of transforming growth factor. So they can be used to prepare the medicines for preventing and treating the diseases associated with fibrosis.

Description

technical field [0001] The invention relates to the field of bioengineering drugs, in particular to a drug for transforming growth factor-β 1 , TGF-β 1 ) sequence and structure of antisense oligonucleotide (antisense oligodeoxynucleotide, ASODN) and its becoming a new drug for preventing fibrosis and treating fibrosis-related diseases. Background technique [0002] Tissue fibrosis is the accumulation of excessive extracellular matrix in specific tissues, which can eventually lead to the reduction or loss of function of affected tissues and organs. Tissue fibrosis can be observed in many diseases, for example, pneumoconiosis (including silicosis, coal lung, etc.), and its common pathogenesis is that dust is inhaled into the alveoli to induce macrophages to release some fibrosis factors to promote Fibroblast proliferation and collagen formation lead to fibrosis; fibrous tissue hyperplasia can be observed in viral, alcoholic, and drug-induced hepatitis, especially in liver ci...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07H21/00C12N15/11A61K31/7125A61P11/00A61P1/16A61P43/00C12N15/113
Inventor 刘韧朱旭东谢琳王正国
Owner INST OF FIELD OPERATION SURGERY NO 3 MILITARY MEDICL UNIV PLA